Evolus, Inc.

NASDAQ (USD): Evolus, Inc. (EOLS)

Last Price

9.47

Today's Change

-0.33 (3.36%)

Day's Change

9.25 - 9.89

Trading Volume

702,712

Profile
EOLS

Exchange:  NASDAQ Global Market NASDAQ Global Market

Currency:  USD USD

Sector:  Healthcare - Healthcare Healthcare - Healthcare

Industry: 

CEO:  Mr. David Moatazedi Mr. David Moatazedi

Full Time Employees:  322 322

IPO Date:  2018-02-08 2018-02-08

CIK:  0001570562 0001570562

ISIN:  US30052C1071 US30052C1071

CUSIP:  30052C107 30052C107

Beta:  1.31 1.31

Last Dividend:  0.00 0.00

Dcf Diff:  14.10 14.10

Dcf:  -0.05 -0.05

Description

Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorporated in 2012 and is headquartered in Newport Beach, California.

Address

520 Newport Center Drive,
Newport Beach, CA 92660, US

949 284 4555

http://www.evolus.com

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment